The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country. The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=102535.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/2013-analysis-of-the-cell-surface-markers-in-europe-hospitals-commercial-labs-ambulatory-care-centers-market-report.html.
No comments:
Post a Comment